Article

PDF
Access to the PDF text
Advertising



Archives of cardiovascular diseases
Volume 108, n° 12
pages 634-642 (décembre 2015)
Doi : 10.1016/j.acvd.2015.07.003
Received : 13 January 2015 ;  accepted : 22 July 2015
Circulating microribonucleic acids miR-1, miR-21 and miR-208a in patients with symptomatic heart failure: Preliminary results
ARN circulant (miR-1, miR-21 et miR-208a) chez les patients ayant une insuffisance cardiaque symptomatique : résultats préliminaires
 

Figure 1




Figure 1 : 

A. Expression of microribonucleic acid-1 (miR-1) in patients with symptomatic heart failure. B. Expression of microribonucleic acid-21 (miR-21) in patients with symptomatic heart failure. NYHA: New York Heart Association.


Figure 2




Figure 2 : 

A. Correlations between serum N-terminal prohormone of B-type natriuretic peptide (NT-proBNP) concentrations and microribonucleic acid-1 (miR-1) expression in patients with symptomatic heart failure in New York Heart Association (NYHA) class II/III. B. Correlations between serum galectin-3 concentrations and microribonucleic acid-21 (miR-21) expression in patients with symptomatic heart failure in NYHA class IV. Spearman's rank correlation coefficients (r ) are indicated.

EM-CONSULTE.COM is registrered at the CNIL, déclaration n° 1286925.
As per the Law relating to information storage and personal integrity, you have the right to oppose (art 26 of that law), access (art 34 of that law) and rectify (art 36 of that law) your personal data. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Close
Article Outline